Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from R. Torrisi and co-authors in the area of breast cancer published
August 28th, 2008
According to recent research from Milan, Italy, " No specific treatment guidelines are available for triple-negative breast cancers, defined by a lack of expression of estrogen (ER), progesterone (PgR), and HER2 receptors. Patients and methods We investigated in patients with T2-T3 N0-3 ER, PgR < 10% and HER2 negative breast cancers the activity both in terms of pathological (pCR) and objective responses of four courses of cisplatin containing chemotherapy (ECF, epirubicin, cisplatin, and fluorouracil as continuous infusion) followed by three courses of weekly paclitaxel." "Adjuvant metronomic chemotherapy including cyclophosphamide and methotrexate for 4-6 months...
Source: Women's Health Weekly (2008-08-28)
|
